Susan Stephens, MSW, LCSW, ACSW, social worker at Rutgers Cancer Institute of New Jersey shares more about providing care to pediatric patients and families.
We know that colorectal cancer screening and early detection and prevention can save lives. Anita Kinney, PhD, shares what resources are available for colorectal cancer screening and how to learn more about them.
Significant disparities persist among some racial and ethnic groups in regards to screening for colorectal cancer. Rutgers Cancer Institute researcher Denalee O'Malley, PhD, focuses her research on this topic. She shares more.
Colorectal cancer has become prevalent among individuals younger than the age of 50 in recent years. Dr. Patrick Boland at Rutgers Cancer Institute shares what we know about this trend.
The U.S. Preventative Services Task Force (USPSTF) recommends that people begin colorectal cancer screening at age 45, rather than 50, which was the previous recommendation.
Dr. Masi Shah of Rutgers Cancer Institute in partnership with RWJBarnabas Heath shares about Multiple Myeloma, a life changing disease with treatments to help control the disease.
Miral Sadaria Grandhi, MD, surgical oncologist in the Liver Cancer and Bile Duct Cancer Program at Rutgers Cancer Institute of New Jersey and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more about gallbladder and bile duct cancer.
Parents of children with cancer experience stress as they navigate and manage their child’s illness. Karen Long-Traynor, PhD, clinical psychologist in the Pediatric Hematology/Oncology Program at Rutgers Cancer Institute of New Jersey whose current research focuses on psychological support for parents during their child’s treatment and through survivorship, shares more on the impact of childhood cancer on parents and ways to cope.
One of the primary modes of cancer prevention and early detection in the United States is the widespread practice of screening. However, not all individuals have access to quality cancer screenings or cancer education, which creates significant disparities in cancer outcomes.
Sanjay Goel, MD, MS has been named director of Rutgers Cancer Institute of New Jersey's Phase I/Investigational Therapeutics Program, a multidisciplinary scientific group designed to develop new methods for the treatment of cancer in collaboration with colleagues across the RWJBarnabas Health system.
Lung cancer is one of the most common cancers in the world and is a leading cause of cancer-related death in men and women in the United States according to the American Cancer Society. Although cigarette smoking is the main cause of lung cancer and quitting would prevent a large number of lung cancer cases, it wouldn't prevent all of them.
The thyroid plays a large role in your overall health. While there is no known way to prevent thyroid cancer, some things that may help to maintain thyroid health are the lifestyle choices you make. Rutgers Cancer Institute of New Jersey experts share more.
Despite a cancer diagnosis and/or cancer treatment, there are smokers who continue with the difficult addiction. As the state’s only National Cancer Institute- designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey now offers a new program, part of the National Cancer Institute’s Moonshot Program, designed to integrate tobacco treatment into the patient-care workflow, to provide state-of-the-art tobacco treatment and cessation support to all patients at no cost.
Cervical cancer is the only gynecologic cancer that can be prevented—and there are numerous tools to promote prevention including vaccines and tested strategies. James K. Aikins, Jr., MD, FACOG, FACS, chief of Gynecologic Oncology at Rutgers Cancer Institute of New Jersey and associate professor of Obstetrics, Gynecology and Reproductive Sciences at Rutgers Robert Wood Johnson Medical School shares more information about cervical cancer prevention through HPV vaccination, routine PAP tests and lifestyle choices.
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center, examined the effects of SIRT1, an enzyme located primarily in the cell nucleus that contributes to cellular regulation on the transformation of T-cells.
Research underway at Rutgers Cancer Institute of New Jersey will contribute to the development of new cancer treatments that are based on the administration of cancer-fighting immune cells to patients.
Investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS) explored how Artificial Intelligence/Machine Learning will complement existing approaches focused on genome-protein sequence information, including identifying mutations in human tumors published online December 2 in The New England Journal of Medicine.
Expert research at Rutgers Cancer Institute of New Jersey focuses on psychosocial aspects of pediatric, adolescent, and young adult cancer survivorship, including survivorship care and health promotion for survivors. Katie Devine, PhD, MPH, is section chief of Pediatric Population Science, Outcomes, and Disparities Research in the Division of Pediatric Hematology/Oncology at Rutgers Cancer Institute shares more.